News room

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Media contact


Nicklas Westerholm, CEO

Marie-Louise Alamaa, CFO

Calendar and upcoming reports

November 4, 2021
Interim report July-September

November 11, 2021
Redeye Life Science Day 2021

Show more events



Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10